What does FutureTech II Acquisition Corp. do?

FutureTech II Acquisition Corp. is a public company in the Biological Products, (No Diagnostic Substances) industry. It is registered with the SEC under CIK 0001889450 and trades on under the ticker FTII.

Is FutureTech II Acquisition Corp. profitable?

FutureTech II Acquisition Corp. reported a net loss of $0.75M in FY2024. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has FutureTech II Acquisition Corp. made?

FutureTech II Acquisition Corp. has filed 151 documents with the SEC since 2021. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

FutureTech II Acquisition Corp.

FTII CIK: 0001889450 Biological Products, (No Diagnostic Substances)

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 151 filings →

Form	Description	Date
8-K	8-K	Mar 10, 2026
8-K	8-K	Feb 19, 2026
8-K	8-K	Jan 16, 2026
RW	RW	Nov 26, 2025
NT 10-Q	NT 10-Q	Nov 14, 2025
8-K	8-K	Nov 12, 2025
10-Q	10-Q	Aug 22, 2025
8-K	8-K	Aug 18, 2025
8-K	8-K	Aug 18, 2025
NT 10-Q	NT 10-Q	Aug 15, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for FutureTech II Acquisition Corp.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: ($747.0K) (FY2024)
Total Assets: $28.12M (FY2024)

Full financials →

Details

CIK: 0001889450
Ticker: FTII
First Filing: 2021
Total Filings: 151

Biological Products, (No Diagnostic Substances) rankings →